Trials / Sponsors / Adaptive Biotechnologies
Adaptive Biotechnologies
Industry · 8 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | ImmuneSense™ IBD Study Inflammatory Bowel Diseases | — | 2022-10-31 |
| Recruiting | Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Mantle Cell Lymphoma | — | 2022-06-01 |
| Withdrawn | ImmuneSense™ COVID-19 Cross-Reactivity Study Coronavirus Disease, SARS-CoV-2 Infection | — | 2021-12-15 |
| Completed | ImmuneSense COVID-19 Variant Study Covid19 | — | 2021-10-12 |
| Terminated | The clonoSEQ® Watch Registry Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma | — | 2020-10-13 |
| Completed | ImmuneSense™ COVID-19 Study Coronavirus Disease (COVID-19), SARS-CoV-2 Infection | — | 2020-10-09 |
| Completed | ImmuneSense Lyme Study Lyme Disease | — | 2020-07-09 |
| Completed | ImmuneRACE - Immune Response Action to COVID-19 Events Covid19 | — | 2020-04-24 |